FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

33622911000001105: Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Dec 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
101469101000001113 Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101469201000001118 Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has specific active ingredient Cabozantinib s-malate true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Is a Cabozantinib 20mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has AMP Cabometyx 20mg tablets (Ipsen Ltd) true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has specific active ingredient Cabozantinib s-malate false Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance cabozantinib false Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has basis of strength substance cabozantinib false Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has basis of strength substance Cabozantinib true Inferred relationship Existential restriction modifier
Cabometyx 20mg tablets (Ipsen Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cabozantinib false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start